ATOSSA GENETICS WKN: A2JJ99 ISIN: US04962H5063 Forum: Aktien Thema: Hauptdiskussion

Atossa Genetics Inc. (ATOS)- Safe Haven Investment Performance Stocks http://nasdaqtimes.com/atossa-genetics-inc-atos-safe-haven-investment-performance-stocks/

PANAGORA ASSET MANAGEMENT INC NOW HOLDS $136 THOUSAND WORTH OF ATOSSA GENETICS INC. (ATOS) https://postanalyst.com/2018/02/05/panagora-asset-management-inc-now-holds-136-thousand-worth-of-atossa-genetics-inc-atos/

https://factsreporter.com/2018/02/05/crazy-volume-spikes-for-atossa-genetics-inc-atos/

Stock to Watch – Atossa Genetics Inc. (ATOS) http://www.usstockjournal.com/2018/02/05/stock-to-watch-atossa-genetics-inc-atos/

https://evergreencaller.com/stochastic-rsi-displaying-bullish-divergence-for-atossa-genetics-inc-atos/

Atossa Genetics (ATOS) hat neue Daten für seinen Brustkrebs-Kandidaten Endoxifen veröffentlicht Analyse: Die Daten zeigten, dass die mediane Zeit für die orale Verabreichung von Endoxifen im Steady-State-Serumspiegel sieben Tage war, wesentlich schneller als orale Tamoxifen, die 50 bis 200 Tage benötigt (beide Medikamente einmal / Tag). Die mittlere Zeit bis zum Erreichen des maximalen Serumspiegels betrug für Endoxifen vier bis acht Stunden (dosisabhängig). Die Tagesdosis von 4 mg erzeugte in diesem Zeitraum einen maximalen Serumspiegel oberhalb der allgemein akzeptierten Schwelle für eine therapeutische Wirkung auf Östrogen-abhängigen Brustkrebs. https://seekingalpha.com/article/4142694-daily-pharma-scoop-medicinovas-mnminus-166-amgens-results-tg-therapeutics-data

Maxim Group Begins Coverage on Atossa Genetics (ATOS) Maxim Group began coverage on shares of Atossa Genetics (NASDAQ:ATOS) in a report issued on Friday, January 26th, MarketBeat.com reports. The brokerage issued a buy rating and a $2.00 price target on the stock. “Tamoxifen is the most widely used drug to prevent breast cancer recurrence... https://www.thelincolnianonline.com/2018/02/03/atossa-genetics-atos-receives-new-coverage-from-analysts-at-maxim-group-updated.html

Sicher nicht :-))) eher 2,60€ :-)))

Ich sags doch, die 0,26€ kommen bald wieder.

Der Kurs dreht noch

http://nasdaqjournal.com/index.php/2018/02/02/atossa-genetics-inc-nasdaqatos-brief-overview-on-stocks-performances/

http://ir.atossagenetics.com/news/detail/837/atossa-genetics-presents-additional-findings-from-its-phase-1-study-of-oral-endoxifen

Kurs und Volumen zieht so langsam an :-))

http://nasdaqtimes.com/atossa-genetics-inc-atos-prime-game-changers-stocks-for-the-day/

Atossa Genetics (ATOS) Earns Coverage Optimism Score of 0.12 https://stocknewstimes.com/2018/02/02/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-atossa-genetics-atos-share-price.html

https://globenewswire.com/news-release/2018/02/01/1330394/0/en/Atossa-Genetics-Presents-Additional-Findings-from-its-Phase-1-Study-of-Oral-Endoxifen.html